Progression of a caval vein thrombus in two patients with primary renal cell carcinoma on pretreatment with sunitinib.
about
The role of neoadjuvant therapy in the management of locally advanced renal cell carcinomaCytoreductive surgery in the era of targeted molecular therapyNeoadjuvant therapy of renal cell carcinoma: a novel treatment option in the era of targeted therapy?Is there a role for systemic targeted therapy after surgical treatment for metastases of renal cell carcinoma?Targeted therapies in renal cell cancer: recent developments in imagingPrognostic benefit of surgical management in renal cell carcinoma patients with thrombus extending to the renal vein and inferior vena cava: 17-year experience at a single center.Phase 2 trial of neoadjuvant axitinib in patients with locally advanced nonmetastatic clear cell renal cell carcinoma.Neo adjuvant treatment with targeted molecules for renal cell cancer in current clinical practise.Selecting patients for cytoreductive nephrectomy in advanced renal cell carcinoma: who and when.Neoadjuvant treatment in advanced renal cell carcinoma: current situation and future perspectives.Do targeted agents offer clinical benefit as presurgical therapy?Role of targeted therapy in combination with surgery in renal cell carcinoma.Early ultrasonographic evaluation of tumor thrombus level during sunitinib therapy for renal cell carcinoma.Is there a role for neoadjuvant targeted therapy to downsize primary tumors for organ sparing strategies in renal cell carcinoma?Pre-operative risk stratification for cancer-specific survival in patients with renal cell carcinoma with venous involvement who underwent nephrectomy.Expression and role of VEGFA and miR-381 in portal vein tumor thrombi in patients with hepatocellular carcinoma.
P2860
Q26749084-A62F12C9-0580-446D-B686-C89006609E63Q26774134-FA0F4717-70C3-4C88-A3E6-93EA6CE32980Q27002583-B6A9C6EB-0BCB-4B96-AC1B-8810203EFB23Q28087518-D8EB91C4-71E9-466E-BE79-6AD986AA485CQ34088696-7D5CCB29-1D5C-4245-AC95-5231E0ABE666Q35017319-7CB36C54-05C0-4BC5-9B00-AA650CB66659Q35413876-B4CEB8F0-225C-4F85-9457-9752B39CBACEQ36084067-A6979B5B-879C-4FBB-AA34-D0C4ECD31047Q38020245-39B5D329-5969-4688-886B-1BD95A98C635Q38068585-5E418F8C-F058-4935-B42E-59CEC53B4DE3Q38084591-01A90AFF-ADCC-4019-B1FD-84B27120B3E3Q38560110-5DE85534-135E-4FD7-AF7C-64E0395F54F5Q39699579-AFFA426F-69DA-471F-8662-BFE83441B180Q41886782-44C79701-0C75-4674-AA72-E8989FD1F829Q43595301-BB2CFA27-4E54-41AB-AE59-902288ABCA94Q55297156-FF3B4E41-C0BD-46AB-B8AB-F0A4ED26555A
P2860
Progression of a caval vein thrombus in two patients with primary renal cell carcinoma on pretreatment with sunitinib.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Progression of a caval vein th ...... n pretreatment with sunitinib.
@en
Progression of a caval vein th ...... n pretreatment with sunitinib.
@nl
type
label
Progression of a caval vein th ...... n pretreatment with sunitinib.
@en
Progression of a caval vein th ...... n pretreatment with sunitinib.
@nl
prefLabel
Progression of a caval vein th ...... n pretreatment with sunitinib.
@en
Progression of a caval vein th ...... n pretreatment with sunitinib.
@nl
P2093
P2860
P1433
P1476
Progression of a caval vein th ...... n pretreatment with sunitinib.
@en
P2093
Astrid A M Van der Veldt
Christian Blank
Epie Boven
John B A G Haanen
P2860
P304
P356
10.3109/02841860903521111
P577
2010-05-01T00:00:00Z